|
|
1) McCormick A, Fleming D, Charlton J. Morbidity statistics from general practice.
Fourth national study 1991-1992. London: HMSO, 1995.
2) Bruijnzeels MA, van Suijlekom-Smit LWA, van der Velden J, van der Wouden
JC. The child in general practice. Rotterdam/Utrecht: Erasmus Universiteit/NIVEL,
1993.
3) Van der Ven-Daane I, Bruijnzeels MA, van der Wouden JC, van Suijlekom-Smit
LWA. Occurrence and treatment of impetigo vulgaris in children. Huisarts Wet
1993; 36: 291-3.
4) Dagan R, Bar-David Y. Double-blind study comparing erythromycin and mupirocin
for treatment of impetigo in children: implications of a high prevalence of
erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother.
1992; 36(2): 287-90.
5) Koning S, van Suijlekom-Smit LW, Nouwen JL, Verduin CM, Bernsen RM, Oranje
AP, Thomas S, van der Wouden JC. Fusidic acid cream in the treatment of impetigo
in general practice: double blind randomized placebo controlled trial. BMJ.
2002; 324: 203-6.
6) Feder HM Jr, Abrahamian LM, Grant-Kels JM. Is penicillin still the drug
of choice for non-bullous impetigo? Lancet. 1991; 338: 803-5.
7) Dagan R. Impetigo in childhood: changing epidemiology and new treatments.
Pediatr Ann. 1993; 22: 235-40.
8) Skin diseases. In: Collier JAB, Longmore JM, HOdgetts(eds). Oxford handbook
of clinical specialities. Fourth edition. Oxford: OUP, 1997; 573-603.
9) Infections. In: Hunter JAA, Savin JA, Dahl MV.(eds). Clinical dermatology.
Second edition. Oxford: Blackwell Science, 1995; 161-93.
10) Hay RJ, Adriaans BM. Bacterial infections. In: Chapman RH, Burton JL, Burns
DA, Breathnach SM(eds). Rook/Wilkinson/Ebling Textbook of dermatology. Six
edition. Oxford: Blackwell Science, 1998; 1097-1179.
11) British Medical Association & Royal Pharmaceutical Society of Great
Britain. Anti-bacterial drugs(5.1). In: British National Formulary. Issue 41.
London: BMJ books, 2001; 252-90.
12) Jaffe GV, Grimshaw JJ. A clinical trial of hydrocortisone/potassium hydroxyquinoline
sulphate ('Quinocort') in the treatment of infected eczema and impetigo in
general practice. Pharmatherapeutica. 1986; 4: 628-36.
13) Nolting S, Strauss WB. Treatment of impetigo and ecthyma. A comparison
of sulconazole with miconazole. Int J Dermatol. 1988; 27: 716-9.
14) Ruby RJ, Nelson JD. The influence of hexachlorophene scrubs on the response
to placebo or penicillin therapy in impetigo. Pediatrics. 1973; 52(6): 854-9.
15) Sharquie KE, al-Turfi IA, al-Salloum SM. The antibacterial activity of
tea in vitro and in vivo (in patients with impetigo contagiosa). J Dermatol.
2000; 27(11): 706-10.
16) Sewell DL. Bacteriology. In: McClatchey KD(ed). Clinical laboratory medicine.
Baltimore: Williams and Wilkins, 1994; 1111-68.
17) Eells LD, Mertz PM, Piovanetti Y, Pekoe GM, Eaglstein WH. Topical antibiotic
treatment of impetigo with mupirocin. Arch Dermatol. 1986; 122(11): 1273-6.
18) Zaynoun ST, Matta MT, Uwayda MM, Kurban AK. Topical antibiotics in pyodermas.
Br J Dermatol. 1974; 90(3): 331-4.
19) Bass JW, Chan DS, Creamer KM, Thompson MW, Malone FJ, Becker TM, Marks
SN. Comparison of oral cephalexin, topical mupirocin and topical bacitracin
for treatment of impetigo. Pediatr Infect Dis J. 1997; 16(7): 708-10.
20) Britton JW, Fajardo JE, Krafte-Jacobs B. Comparison of mupirocin and erythromycin
in the treatment of impetigo. J Pediatr. 1990; 117(5): 827-9.
21) Koranyi KI, Burech DL, Haynes RE. Evaluation of bacitracin ointment in
the treatment of impetigo. Ohio State Med J. 1976; 72(6): 368-70.
22) George A, Rubin G. A systematic review and meta-analysis of treatments
for impetigo. Br J Gen Pract. 2003 Jun;53(491):480-7.
23) Gilbert M. Topical 2% mupirocin versus 2% fusidic acid ointment in the
treatment of primary and secondary skin infections. J Am Acad Dermatol. 1989;
20(6): 1083-7.
24) Morley PA, Munot LD. A comparison of sodium fusidate ointment and mupirocin
ointment in superficial skin sepsis. Curr Med Res Opin. 1988; 11(2): 142-8.
25) Sutton JB. Efficacy and acceptability of fusidic acid cream and mupirocin
ointment in facial impetigo. Curr Ther Res 1992; 51: 673-8.
26) White DG, Collins PO, Rowsell RB. Topical antibiotics in the treatment
of superficial skin infections in general practice--a comparison of mupirocin
with sodium fusidate. J Infect. 1989; 18(3): 221-9.
27) Jaffe AC, OfBrien CA, Reed MD, Blumer JL. Randomized comparative evaluation
of augmentin® and cefaclor in pediatric skin and soft tissue infections. Curr
Ther Res 1985; 38: 160-8.
28) Demidovich CW, Wittler RR, Ruff ME, Bass JW, Browning WC. Impetigo. Current
etiology and comparison of penicillin, erythromycin, and cephalexin therapies.
Am J Dis Child. 1990; 144(12): 1313-5.
29) McVicar J. Towards evidence based emergency medicine: best BETS from the
Manchester Royal Infirmary. Oral or topical antibiotics for impetigo. J Accid
Emerg Med. 1999; 16(5): 364-5.
30) Stringel G, Bawdon R, Savrich M, Guertin L, Horton J. Topical and systemic
antibiotics in the prevention of wound infection. J Pediatr Surg. 1989; 24(10):
1003-6.
31) Bareggi SR, Pirola R, De Benedittis G. Skin and plasma levels of acetylsalicylic
acid: a comparison between topical aspirin/diethyl ether mixture and oral aspirin
in acute herpes zoster and postherpetic neuralgia. Eur J Clin Pharmacol. 1998;
54(3): 231-5. |
|
![ΉΗ]Ώ\κ](image/link_01.gif)
![]Ώ\Μ©ϋ](../image/link_02.gif){kind=small}
![]Ώ@Μ©ϋ](../image/link_03.gif){kind=small}
